Fresenius Medical Care AG(FMS)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

Fresenius Medical Care AG (FMS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores FMS at 50.4/100 on a 32-signal composite quality model, placing it at rank #1,602 of 2,962 stocks — the bottom half of the AI-ranked universe. FMS scores in the top quartile across revenue scale (91.5). Areas of concern include revenue growth (18.9) and institutional flow (22.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q4 2016), Fresenius Medical Care AG reports net income of $388.1M, free cash flow of $561.2M. Top institutional holders of FMS by reported 13-F value include PZENA INVESTMENT MANAGEMENT, MORGAN STANLEY, DODGE & COX, based on the most recent SEC filings. FMS trades on the NYSE exchange and files with the SEC under CIK 1333141. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate FMS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Fresenius Medical Care AG directly from SEC EDGAR.